Floatz logo

IODINE I-131

Lymphoma, B-Cell

Duke UniversitySmall moleculePhase 2Dormant
CCC
54/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
42/ 100
Competitive Position
73/ 100

Competitive context

51 Active assets in the Lymphoma, B-Cell cohort.

Asset / SponsorPhaseRating
cd19-ucart
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 4BB
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Mwanasha Merrill, MD
Phase 4BB
Cyclophosphamide
Swiss Cancer Institute
Phase 4BB
(+)-VINCRISTINE
Mwanasha Merrill, MD
Phase 4BB
Inno-206
Mwanasha Merrill, MD
Phase 4BB

View all 50 →

Same molecule, other indications

IODINE I-131 is also rated in:

LymphomaDormant
B
Indicative ·
59 / 100
View asset →
Multiple MyelomaDormant
C
Indicative ·
39 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →